SCHEMBL12014172

SCHEMBL12014172

CC(C)[N+]1(C)CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL11438442 0.76
Hydrochloric Acid SCHEMBL15574505 0.76
SCHEMBL8945280 0.74
SCHEMBL1223459 0.74
SCHEMBL12381016 0.73
SCHEMBL5289077 0.71
SCHEMBL12964271 0.69 LMNA (0.33)
SCHEMBL16766321 0.69
SCHEMBL21534095 0.69
SCHEMBL12014171 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207260-A1 METHODS FOR TREATING CHOLESTASIS MIRUM PHARMACEUTICALS, INC. (US) 2024-06-27 US disclosed
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. 2023-08-17 US disclosed
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-05-23 US disclosed
EP-2809739-B1 IONIC LIQUIDS FOR COOLING IN HIGH TEMPERATURE ENVIRONMENT PROIONIC GMBH (AT) 2020-12-09 EP disclosed
US-10677532-B2 Ionic liquids for cooling in high temperature environment PROIONIC GMBH (AT) 2020-06-09 US disclosed
EP-2809611-B1 USE OF AN IONIC LIQUID FOR STORING HYDROGEN PROIONIC GMBH (AT) 2020-02-05 EP disclosed
US-9868635-B2 Use of an ionic liquid for storing hydrogen PROIONIC GMBH (AT) 2018-01-16 US disclosed
US-9517244-B2 Therapeutic combinations for use in neoplasia UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2016-12-13 US disclosed
US-9517244-B2 Therapeutic combinations for use in neoplasia UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2016-12-13 US disclosed
US-9481709-B2 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism OBE THERAPY BIOTECHNOLOGY (FR) 2016-11-01 US disclosed
US-8476388-B2 Polymeric acid catalysts and uses thereof Midori Renewables, Inc. (US) 2013-07-02 US disclosed
US-8466242-B2 Polymeric acid catalysts and uses thereof Midori Renewables, Inc. (US) 2013-06-18 US disclosed
US-20130042859-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF Midori Renewables, Inc. (US) 2013-02-21 US disclosed
US-20120252957-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF Midori Renewables, Inc. (US) 2012-10-04 US disclosed
US-20120220740-A1 POLYMERIC ACID CATALYSTS AND USES THEREOF Midori Renewables, Inc. (US) 2012-08-30 US disclosed
US-20100311690-A1 BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM OBE THERAPY BIOTECHNOLOGY (FR) 2010-12-09 US disclosed
US-20090005321-A1 Phenylazetidinone Derivatives MICROBIA, INC. (US) 2009-01-01 US disclosed
US-20080167255-A1 4-BIARYLYL-1-PHENYLAZETIDIN-2-ONES MICROBIA, INC. (US) 2008-07-10 US disclosed
US-20080167255-A1 4-BIARYLYL-1-PHENYLAZETIDIN-2-ONES MICROBIA, INC. (US) 2008-07-10 US disclosed
US-7320972-B2 4-Biarylyl-1-phenylazetidin-2-ones MICROBIA, INC. (US) 2008-01-22 US disclosed